Developer-first security tool blocks AI manipulation attacks in under 100 milliseconds with a single API call Our goal ...

BRIDGEPORT — Despite facing nearly 100 criminal charges related to alleged absentee ballot fraud during two mayoral races, Democrat Wanda Geter-Pataky is among nine community leaders being honored ...

The flagship cryptocurrency continued to crater on Thursday, breaking through several key levels and crashing through $61,000 later in the day. Bitcoin is down by nearly 30% this week alone. This ...

Sleep is a critical physiological process that allows the body to rest, repair and rejuvenate and it has profound implications for systemic health, particularly the cardiovascular system. Along with ...

Accelerate your tech game Paid Content How the New Space Race Will Drive Innovation How the metaverse will change the future of work and society Managing the ...

REDMOND, Wash. — Jan. 8, 2026 — Microsoft Corp. on Thursday announced agentic AI solutions designed to bring intelligent automation to every part of the retail business. These new capabilities help ...

David Slotnick is TPG's contributing aviation editor. He covers the ins and outs of the airline industry. The cards we feature here are from partners who compensate us when you are approved through ...

Forbes contributors publish independent expert analyses and insights. Paul Hsieh, M.D., covers healthcare economics, innovation, and policy. It is too easy to focus on bad news and stressful events, ...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. (ENLV) ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced ...

Professor Philip Conaghan, MBBS, PhD, FRACP, FRCP, is an internationally renowned leader in osteoarthritis and musculoskeletal imaging, and the Consultant Rheumatologist and Director of the NIHR Leeds ...

Nes-Ziona, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Enlivex Therapeutics Ltd. ( Nasdaq: ENLV, the “Company”), a clinical-stage macrophage reprogramming immunotherapy company, today announced positive ...